Industry
Biotechnology
Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.
Loading...
Open
0.99
Mkt cap
175M
Volume
848K
High
1.02
P/E Ratio
2.86
52-wk high
21.09
Low
0.97
Div yield
N/A
52-wk low
0.26
Portfolio Pulse from
November 08, 2024 | 9:00 pm
Portfolio Pulse from Benzinga Newsdesk
October 31, 2024 | 2:56 pm
Portfolio Pulse from Benzinga Newsdesk
October 29, 2024 | 7:37 pm
Portfolio Pulse from Benzinga Newsdesk
October 29, 2024 | 4:45 pm
Portfolio Pulse from Benzinga Insights
October 28, 2024 | 4:30 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.